Fabrication of PEG-PLGA Microparticles with Tunable Sizes for Controlled Drug Release Application

Abstract

Polymeric microparticles of polyethyleneglycol-polylactic acid-co-glycolic acid (PEG-PLGA) are widely used as drug carriers for a variety of applications due to their unique characteristics. Although existing techniques for producing polymeric drug carriers offer the possibility of achieving greater production yield across a wide range of sizes, these methods are improbable to precisely tune particle size while upholding uniformity of particle size and morphology, ensuring consistent production yield, maintaining batch-to-batch reproducibility, and improving drug loading capacity. Herein, we developed a novel scalable method for the synthesis of tunable-sized microparticles with improved monodispersity and batch-to-batch reproducibility via the coaxial flow-phase separation technique. The study evaluated the effect of various process parameters on microparticle size and polydispersity, including polymer concentration, stirring rate, surfactant concentration, and the organic/aqueous phase flow rate and volume ratio. The results demonstrated that stirring rate and polymer concentration had the most significant impact on the mean particle size and distribution, whereas surfactant concentration had the most substantial impact on the morphology of particles. In addition to synthesizing microparticles of spherical morphology yielding particle sizes in the range of 5–50 µm across different formulations, we were able to also synthesize several microparticles exhibiting different morphologies and particle concentrations as a demonstration of the tunability and scalability of this method. Notably, by adjusting key determining process parameters, it was possible to achieve microparticle sizes in a comparable range (5–7 µm) for different formulations despite varying the concentration of polymer and volume of polymer solution in the organic phase by an order of magnitude. Finally, by the incorporation of fluorescent dyes as model hydrophilic and hydrophobic drugs, we further demonstrated how polymer amount influences drug loading capacity, encapsulation efficiency, and release kinetics of these microparticles of comparable sizes. Our study provides a framework for fabricating both hydrophobic and hydrophilic drug-loaded microparticles and elucidates the interplay between fabrication parameters and the physicochemical properties of microparticles, thereby offering an itinerary for expanding the applicability of this method for producing polymeric microparticles with desirable characteristics for specific drug delivery applications.

Preparation of kartogenin-loaded PLGA microspheres and a study of their drug release profiles

“…Several studies have reported that particle fabrication formulations, such as polymer concentration, solvent ratio, and surfactant, affect encapsulation efficiency of the drug-loaded particles (Lagreca et al, 2020;Sagoe et al, 2023). Figure 5 illustrates the encapsulation efficiency (EE) and drug loading capacity (DL) of the microspheres.…”

Applications of Supramolecular Polymers Generated from Pillar[n]arene-Based Molecules

“…This strategy can achieve the desired outcome, reducing biological toxicity [236][237][238]. Supramolecular interactions are promising for achieving site-specific drug or biomolecule release and addressing biological barriers [239][240][241][242][243][244][245]. The following section presents several drug delivery systems based on pillar[n]arene derivatives.…”